Valerio Apicella
Sapienza University of Rome(IT)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913(2020)80 cited
- → Comparative analysis between RQ‐PCR and digital‐droplet‐PCR of immunoglobulin/T‐cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia(2016)69 cited
- → Rapid identification of BCR/ABL1‐like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time‐polymerase chain reaction: clinical, prognostic and therapeutic implications(2018)60 cited
- → RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications(2016)48 cited
- → Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes(2016)34 cited
- → Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia(2019)29 cited
- → Clinical significance of recurrent copy number aberrations in B‐lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts(2017)25 cited
- → Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia(2022)10 cited
- → Comparative Analysis between RQ-PCR, Digital-Droplet-PCR and Next-Generation-Sequencing (NGS) of Immunoglobulin/T-Cell Receptor Gene Rearrangements to Monitor Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia Patients(2018)3 cited
- → Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia(2022)2 cited